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A B S T R A C T
Central and South American countries (including Cuba) are experiencing rapid socio-demographic and
epidemiologic changes and the nature of health problems are undergoing transition from infectious to
chronic diseases, including cancer. Countries are poorly prepared to respond effectively to the
subsequent challenges posed by the new patterns of disease. Existing data delineating the number of
cancer cases and the distribution of cancer types from each country in the region are sparse due to
limitations on health information systems for recording incidence and mortality despite improvements
made in recent years. There is an urgent need for reliable statistics on cancer to inform governmental
entities responsible for cancer control in the region. We attempted to obtain the best available cancer
data from each country located in the region to provide an overview of current geographic patterns of
cancer incidence and mortality in the 21st century.
ã 2015 International Agency for Research on Cancer; Licensee Elsevier Ltd. This is an open access article
under the CC BY-NC-ND IGO 3.0 license (https://creativecommons.org/licenses/by-nc-nd/3.0/igo/).
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Non-communicable diseases (NCDs) – including cancer,
cardiovascular diseases, stroke, and diabetes, among others –
are the leading contributors to the global disease burden [1]. In
low- and middle-income countries, NCDs now surpass infectious
diseases as causes of death; this transition is multifactorial, a
consequence of demographic changes (in aging and population
growth), exposure to risk factors (i.e. smoking, harmful use of
alcohol), and a substantial decline in infections as a cause of
infant death [1,2]. As in many other parts of the world, countries
in Central and South America (including Cuba) have been
undergoing rapid urbanization which has been accompanied by
an increased burden of NCDs [3]. The levels of urbanization in the
region have increased from 65 to 74% in 1990 to 73 to 83% in 2014,
comparable to the urbanization levels of North America and many
European countries [3]. The economy in the Central and South
American region has grown at a steady pace since the 1980s, as$ This is an Open Access article published under the CC BY NC ND 3.0 IGO license
which permits users to download and share the article for non-commercial
purposes, so long as the article is reproduced in the whole without changes, and
provided the original source is properly cited. This article shall not be used or
reproduced in association with the promotion of commercial products, services or
any entity. There should be no suggestion that IARC endorses any speciﬁc
organisation, products or services. The use of the IARC logo is not permitted. This
notice should be preserved along with the article’s original URL.
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creativecommons.org/licenses/by-nc-nd/3.0/igo/).represented by the overall increases in per-capita gross domestic
product (GDP) and human development index (HDI), and by
declines in income inequality (Gini coefﬁcient) from nearly 60 in
1980 to the 40s in 2010 [4,5] (Tables 1 and 2). Countries are
spending a larger percentage of their per-capita GDP on public
health, although this percentage varies considerably across the
region, with more afﬂuent countries generally spending more
than their poorer counterparts (ranging from 2.1 in Paraguay to
7.4 in Costa Rica and 9.7 in Cuba for the year 2010). In recent
decades, infant mortality has declined remarkably and life
expectancy has increased. For example, life expectancy in
Honduras (a country of medium human development) increased
by more than 13 years between 1980 and 2010 (59.4 versus
72.8 years), while infant mortality signiﬁcantly decreased
between 1990 and 2010 (58 deaths versus 24 deaths per 1000
live births in 2010) [4] (Table 1). Population estimates indicate
striking increases in population size since the 1960s as well as
changes in the distribution of age groups; the proportion of the
population under 15 years declined while the proportion of the
population aged over 65 years increased [6]. This may, in part, be
a result of the investment of individual countries in universal
health care and improvements in the public health services and
implementation of health policies [7–14]. The Central and South
American region (including Cuba) have simultaneously experi-
enced a complex epidemiologic transition from mortality due to
communicable, maternal, and perinatal diseases to mortality due
to NCDs [1,2,15–17]. In 2008, mortality due to NCDs accounted for
50–87% of total deaths in the region, with cancer carrying 8–25%. This is an open access article under the CC BY-NC-ND IGO 3.0 license (https://
Table 1
Selected economic and health indicators by country (from [4;5]).
Year Argentina Belize Bolivia Brazil Chile Colombia Costa
Rica
Cuba Ecuador French
Guyana
[21]
Guatemala Guyana Honduras Mexico
Economic indicators
GDP per capita (2005
PPP $)a
1980 10,075 3342 3779 7567 5654 5297 6378 5699 3873 2059 2820 10,238
2005 10,833 6254 3772 8509 12,663 7305 9042 6510 4062 2536 3277 12,191
2010 14,363 5980 4350 10,093 14,540 8479 10,453 7201 4297 3104 3519 12,441
Human development
index (HDI) valueb
1980 0.68 0.62 0.49 0.52 0.64 0.56 0.62 0.63 0.60 0.43 0.51 0.46 0.60
2005 0.77 0.69 0.65 0.70 0.79 0.68 0.73 0.74 0.68 0.85 0.55 0.61 0.58 0.75
2010 0.81 0.70 0.67 0.73 0.81 0.71 0.77 0.78 0.72 0.58 0.63 0.63 0.77
Income Gini
coefﬁcientc
1980 59.1
2005 49.3 57.4 56.1 47.6 54.1 59.7
2010 44.5 55.9 49.3
Public expenditure
Education (% of
GDP)d
1980 2.6 4.4 1.7 7.3 8.4 3.0
2005 4.5 3.4 4.0 10.6 8.1 5.0
2010 4.8 12.9 3.7
Expenditure on
health, public (% of
GDP)d
2000 5.0 2.2 2.9 3.4 5.5 5.0 6.1 1.3 2.2 4.6 3.0 2.4
2005 4.6 2.1 3.3 2.8 5.3 5.3 8.7 2.1 2.2 6.0 3.8 2.6
2010 4.4 3.3 4.2 3.8 5.5 7.4 9.7 3.0 2.5 5.1 4.4 3.1
Health indicators
Life expectancy at
birth (years)e
1980 69.4 70.2 62.5 69.2 65.5 72.5 73.5 62.9 57.3 59.5 59.4 66.6
2005 74.8 74.5 71.6 78.4 72.3 78.6 77.7 74.7 72/78
(m/f)
69.7 67.3 71.4 75.6
2010 75.7 75.9 73.1 79.0 73.5 79.2 79.0 75.5 70.9 69.6 72.8 76.7
Health indexf 1980 0.78 0.79 0.67 0.78 0.72 0.83 0.84 0.68 0.59 0.62 0.62 0.74
2005 0.87 0.86 0.81 0.92 0.83 0.92 0.91 0.86 0.78 0.75 0.81 0.88
2010 0.88 0.88 0.84 0.93 0.84 0.93 0.93 0.88 0.80 0.78 0.83 0.90
Under-ﬁve mortality
(per 1000 live
births)g,h
1990 27 44 59 19 37 17 13 52 18 78 66 58 49
2010 14 17 19 9 19 10 6 20 32 30 24 17
a GDP, gross domestic product (PPP, purchasing power parity).
b HDI, the average achievement in three basic dimensions of human development: a long and healthy life, knowledge, and a decent standard of living.
c Measure of the deviation of the distribution of income (or consumption) among individuals or households within a country from a perfectly equal distribution. A value of
0 represents absolute equality, a value of 100 absolute inequality.
d Current and capital spending from government (central and local) budgets, external borrowings and grants (including donations from international agencies and non-
governmental organizations), and social (or compulsory) health insurance funds, expressed as a percentage of GDP.
e Number of years a newborn infant could expect to live if prevailing patterns of age-speciﬁc mortality rates at the time of birth stay the same throughout the infant’s life.
f Life expectancy at birth expressed as an index using a minimum value of 20 years and observed maximum value over 1980–2010.
g Probability of dying between birth and exactly 5 year of age, expressed per 1000 live births.
h Mortality data are of variable quality in this region [22].
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economic impact, particularly for lower-income countries with
insufﬁcient economic resources to respond to this emerging
public health problem [13,14,19,20].
2. Estimating the burden of cancer in Central and South
America
The GLOBOCAN project has estimated that approximately
14 million cancercases and 8.2 million cancer deaths were estimated
to have occurred worldwide in 2012 (excluding non-melanoma skin
cancer), with one million cancer cases and more than half a million
cancer deaths occurring in Central and South America [23].
GLOBOCAN further predicts that these latter ﬁgures will increase
to 1.7 million new cancer cases and 1 million cancer deaths by 2030,
due to the growth and aging of the population (and without taking
changes in underlying risk into account); corresponding to an
increase of around 75% [23]. In 2012, GLOBOCAN indicates that the
most common cancer diagnoses and causes of cancer-related death
in the Central and South American region were prostate, lung,
colorectum, and stomach cancers for males and breast, cervix,
colorectum and lung for females (Fig. 1). In South America, the
incidence of prostate cancer was similar to the incidence in more
developed regions of the world (60.1 versus 68.0 per 100,000,
respectively). Infection-relatedcancers suchascervixandstomach
cancers – are higher in Central and South America as compared to
more developed regions of the world. Although cancer incidence in
Central and South America is, in general, lower than the cancerincidence in more developed regions of the world, mortality is
remarkably higher. This may be explained in part by more advanced
stages at cancer diagnosis and by poorer access to cancer diagnostic,
screening and treatment services [7].
Nevertheless, the cancer proﬁle between countries for the
2012 estimates is markedly different, depending on the measure of
disease frequency evaluated. In males, prostate cancer incidence
was estimated to be highest in Cuba and lowest in Bolivia
(84.2 versus 25.9 per 100,000, respectively). Lung cancer incidence
rates were estimated as being highest in Brazil and Cuba (21.3 and
42.8), while mortality rates were highest in Argentina, Cuba,
Paraguay, Uruguay and Venezuela (18.7–47.3). Countries with the
lowest incidence rates of lung cancer also experienced the lowest
mortality rates (i.e. Bolivia, Guatemala, Guyana and Honduras).
Stomach cancer incidence and mortality were highest in Chile,
Colombia, Costa Rica, Ecuador, El Salvador, and Guatemala and are
lowest in French Guyana, Guyana, and Suriname. In females, breast
cancer incidence and mortality rates were highest in Argentina and
Uruguay and lowest in Bolivia. Brazil also had one of the highest
estimated incidence rates of breast cancer, but mortality was lower
(59.5 versus 14.3), whereas in Guyana estimated incidence was
relatively low and mortality high (50.4 versus 20.1). Cervical cancer
incidence and mortality rates were highest in Bolivia, Guyana,
Nicaragua, Paraguay, and Suriname. French Guyana and Venezuela
also had high incidence rates but lower mortality rates. These
estimates reﬂect the ongoing transition from infection-related
cancers (typical of countries of low human development) to those
cancers usually observed in the most afﬂuent countries. Regional
Table 2
Selected economic and health indicators by country (from [4,5]).
Year Nicaragua Panama Peru Paraguay El
Salvador
Suriname Uruguay Venezuela HDI United
States
Very
high
High Medium Low
Economic indicators
GDP per capita (2005 PPP $)a 1980 2748 6558 6083 4047 4372 6588 7809 11,594 19,686 7928 1051 1136 25,510
2005 2336 9167 6387 3901 5702 6129 9683 9924 31,804 9797 3366 1345 42,516
2010 2499 12,639 8558 4648 5978 7110 12,642 10,973 32,548 11,228 4887 1597 42,079
Human development index
(HDI) valueb
1980 0.46 0.63 0.58 0.55 0.47 0.66 0.63 0.77 0.61 0.42 0.32 0.84
2005 0.57 0.75 0.70 0.64 0.66 0.67 0.74 0.69 0.89 0.73 0.59 0.42 0.92
2010 0.59 0.77 0.73 0.67 0.68 0.68 0.79 0.74 0.90 0.75 0.63 0.46 0.93
Income Gini coefﬁcientc 2005 40.5 54.0 51.1 52.5 50.3 45.9
2010 51.9 48.1 52.4 45.3
Public expenditure on
education (% of GDP)d
1980 3.3 4.3 2.2 5.2 4.4 2.5 3.0
2005 2.7 2.7 2.7 5.0 4.6 3.6 3.3 5.3
2010 2.7 3.2 3.8 4.1 4 3.7
Expenditure on health, public
(% of GDP)d
2000 3.7 5.3 2.8 3.7 3.6 3.9 6.1 6.0 2.9 1.8 1.4 5.8
2005 4.5 5.2 2.7 2.8 3.8 3.5 4.1 6.6 3.1 1.8 1.6 6.7
2010 4.9 6.1 2.7 2.1 4.3 3.4 5.6 8.2 3.6 2.4 1.8 9.5
Health indicators
Life expectancy at birth
(years)e
1980 58.5 69.9 60 66.8 56.6 65.9 70.2 73.4 64.8 61.4 50.1 73.9
2005 72.0 75.1 72.5 71.2 70.9 68.8 75.8 78.9 71.4 68.0 56.2 77.6
2010 73.8 76.0 73.8 72.3 72.0 70.3 76.8 79.8 72.9 69.3 58.3 78.4
Health indexf 1980 0.61 0.79 0.63 0.74 0.58 0.72 0.79 0.84 0.71 0.65 0.48 0.85
2005 0.82 0.87 0.83 0.81 0.80 0.77 0.88 0.93 0.81 0.76 0.57 0.91
2010 0.85 0.88 0.85 0.82 0.82 0.79 0.90 0.94 0.83 0.78 0.60 0.92
Under-ﬁve mortality (per
1000 live births)g,h
1990 68 33 78 50 62 52 23 11 49 79 165 11
2010 27 20 19 25 16 31 11 6 18 42 110 8
a GDP, gross domestic product (PPP, purchasing power parity).
b HDI, the average achievement in three basic dimensions of human development: a long and healthy life, knowledge and a decent standard of living.
c Measure of the deviation of the distribution of income (or consumption) among individuals or households within a country from a perfectly equal distribution. A value of
0 represents absolute equality, a value of 100 absolute inequality.
d Current and capital spending from government (central and local) budgets, external borrowings and grants (including donations from international agencies and non-
governmental organizations), and social (or compulsory) health insurance funds, expressed as a percentage of GDP.
e Number of years a newborn infant could expect to live if prevailing patterns of age-speciﬁc mortality rates at the time of birth stay the same throughout the infant’s life.
f Life expectancy at birth expressed as an index using a minimum value of 20 years and observed maximum value over 1980–2010.
g Probability of dying between birth and exactly 5 year of age, expressed per 1000 live births.
h Mortality data are of variable quality in this region [22].
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and reﬂect differences in risk-factor exposure patterns. Variations
in mortality reﬂect the variation in incidence combined with
variation in disease prognosis resulting from early detection and
access to effective health care. The latter also contributes to
variation in survival, a further metric that has been used to make
international comparisons in capacity for cancer control [24].
Apart from variations between countries, there are also important
variations between regions and populations within countries,
reﬂecting important local geographic and socioeconomic stratiﬁ-
cation.
3. Health systems and current policies
The demographic and epidemiologic transition in Latin America
(including Cuba) has brought an increased burden of NCDs and
chronic conditions which also place a strain upon healthcare
systems since they were designed to provide episodic and acute
care; thus countries have been unable to effectively respond to this
new problem [8,19]. Since the 1980s, Latin America has strength-
ened its health systems in order to reduce social inequalities in
health. Although most countries introduced universal health
coverage after the 1990s, inequities still exist and universal
coverage remains a challenge given (a) the organization of health
systems, (b) inequity of ﬁnancing, (c) the necessity to develop
health services that can meet emerging health needs arising from
social demographic transitions, (d) rapid urbanization, and (e) the
sustainability of investments needed to achieve and maintain
universal coverage [8].Countries in the Central and South American region have
pledged to reduce premature deaths (between 30 and 70 years)
from cancer and other NCDs by 25% by the year 2025 [18,25]. This
requires the implementation of cost-effective policies and services
to prevent cancer, and also requires increasing access to screening,
diagnosis, treatment and palliative care, among other measures
such as reduction in tobacco and alcohol use [26,27]. A survey
assessing the national capacity for the prevention and control of
NCDs [28] revealed that, as of 2013, most of the Central and South
American countries and Cuba have recently developed operational
policies, strategies or action plans speciﬁcally for cancer. However,
only Argentina, Brazil, Chile, Cuba and Nicaragua are fully
implementing them. Countries such as Belize, Ecuador, Mexico,
Nicaragua and Panama are moving forward with the development
of evidence-based guidelines, protocols or standards speciﬁcally
for the management of cancer (Table 3). As is apparent from
Table 3, several countries within the region have an absence (or
paucity) of relevant information that would enable appropriate
monitoring of their cancer control strategies.
Overall, 30–50% of cancers may be prevented by avoiding
known risk factors, and for the remaining cancers cause-speciﬁc
mortality maybe reduced though early detection and effective
treatment [29,30]. Behavioral factors such as tobacco smoking,
alcohol abuse, unhealthy diet, physical inactivity and obesity,
among other environmental factors, are responsible for 66% of all
cancers; infections with the human papilloma virus, hepatitis B
and C, and Helicobacter pylori are collectively associated with 18% of
all cancers; and environmental factors such as air pollution and
aﬂatoxins with 4% of all cancers [29,30]. In Latin America, alcohol
use, increased body weight and smoking were among the ﬁve
Fig. 1. Estimated age-standardized incidence and mortality rates per 100,000 of the top ten cancers in Central and South America in 2012, by sex.
Table 3
Operational policies, strategies or action plans for cancer and for selected risk factors for non-comunicable diseases (from [28]).
Countrya Cancer Policies, plans and strategies for speciﬁc risk factors
Operational policy, strategy or
action plan
(ﬁrst year)
Availability and
implementation of
management guidelines
Tobacco (ﬁrst
year)
Harmful use of
alcohol
(ﬁrst year)
Overweight/
obesity
(ﬁrst year)
Physical
inactivity
(ﬁrst year)
Unhealthy
diet
(ﬁrst year)
Availability Implementation
Argentina 2010 Yes Fully 2004 2011 2012 2011 2008
Belize UD No No No UD No No No
Bolivia 2009 Yes Partially 2007 2007 No No No
Brazil 2005 Yes Fully 1997 No UD 2011 1999
Chile 2005 Yes Fully 2005 2010 2011 2011 2005
Colombia 2013 Yes Partially 2011 2011 UD 2011 2011
Costa Rica 2011 Yes Partially 2012 UD UD 2012 2012
Cuba 2009 Yes Fully 2002 2002 2008 2000 UD
Ecuador UD No No 2011 2013 No No No
El
Salvador
2011 Yes Partially 2006 2012 UD UD UD
Guatemala 2011 Yes Partially 2008 No UD UD No
Honduras 2010 Yes Partially 2010 No No No No
Mexico UD Yes DK UD N/A UD UD UD
Nicaragua UD Yes Fully 2010 No UD No No
Panama UD Yes Partially 2008 2005 2009 2010 2007
Paraguay 2008 Yes Partially 2005 Not in effect No 2013 UD
Peru 2012 Yes Partially UD 2005 UD UD UD
Suriname Not in effect Yes Partially Operationalb Operationalb Nob N/Ab Nob
Uruguay 2006 Yes Partially 2005 No No 2009 UD
Venezuela 1946 Yes Partially 1984 UD UD UD DK
N/A, not available; UD, under development; DK, do not know.
a No data available for French Guyana and Guyana.
b Information obtained from [18].
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Table 4
General availability of tests and procedures for cancer screening at the primary healthcare level (from [28]).
Countrya Cervix Colorectum Breast General availability of
procedures for the treatment
of cancer in the public sector
Pap Visual inspection
with acetic acid
FOT or FIT Colonoscopy Clinical breast
examination
Mammography
Public/
private
sectors
Trained
staffb
Public/
private
sectors
Trained
staffb
Public/
private
sectors
Trained
staffb
Public/
private
sectors
Trained
staffb
Public/
private
sectors
Trained
staffb
Public/
private
sectors
Trained
staffb
Radiotherapy Chemotherapy
Argentina Both Yes Both Yes Both Yes Both Yes Both Yes Both Yes Yes Yes
Belize Both Yes No DK Both Yes Both Yes Both Yes Private Yes No No
Bolivia Both Yes Private Yes Both Yes Private Yes Both Yes Private Yes Yes Yes
Brazil Both Yes No DK Both DK Both DK Both Yes Both Yes Yes Yes
Chile Both Yes No No Both Yes Both Yes Both Yes Both Yes Yes Yes
Colombia Both Yes Both Yes Both Yes Both Yes Both Yes Both Yes Yes Yes
Costa Rica Both Yes Both Yes Both Yes Both Yes Both Yes Private Yes No No
Cuba Public Yes No Yes Public Yes Public Yes Public Yes Public Yes Yes Yes
Ecuador Both Yes No DK Both No Private Yes Both Yes Private No Yes Yes
El
Salvador
Both Yes Both Yes Private No Private No Both Yes Private No Yes Yes
Guatemala Private No Public Yes Private Yes Private Yes Both Yes Private Yes Yes Yes
Honduras Both Yes No No Private Yes Private Yes Both Yes Private Yes Yes Yes
Mexico Both Yes DK DK DK DK DK DK Both Yes Both Yes Yes Yes
Nicaragua Both Yes Both Yes Both Yes Both Yes Both Yes Both Yes Yes Yes
Panama Both Yes No No Both Yes No No Both Yes Private No Yes Yes
Paraguay Both Yes No No No No No No Both Yes No No No Yes
Peru Both Yes No No No No No No No No No No No No
Suriname Both Yes Both Yes Both Yes Both Yes Both Yes Both Yes Yes Yes
Uruguay Both Yes Private Yes Both Yes Both Yes Both Yes Both Yes Yes Yes
Venezuela Both Yes Both Yes Both Yes Both Yes Both Yes Both Yes Yes Yes
N/A, Not available; DK, do not know; FOT, fecal occult blood test; FIT, fecal immunological test.
a No data available for French Guyana and Guyana.
b Are there trained staff available?
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remarkable progress with respect to tobacco control in the Central
and South American region since the mid-2000s, there is work to
do regarding the harmful use of alcohol, overweight/obesity,
physical inactivity, and unhealthy diets [28] (Table 3).
While not all cancers can be prevented, early detection may
lead to improved cancer outcomes by identifying early-stage
disease which is more likely to respond to treatment [29].
Regarding cancer screening tests, as of 2013, most countries in
the region had cervical cytology services – Pap (most frequent) and
visual inspection with acetic acid  and breast cancer screening –
clinical breast examination (most frequent) and/or mammography
 generally available in the public and private sectors. Even though
most countries had colorectal screening (fecal occult blood test or
fecal immunological test) generally available in the public and
private sectors, colonoscopy examinations were generally available
in the private sector. Cancer treatments such as radiotherapy and
chemotherapy were generally available in the public sector in the
majority of countries in Central and South America [28] (Table 4).
According to the Pan-American Health Organization, as of 2013,
most cancer cases are diagnosed at an advanced disease stage
when treatment is less effective; thus patients require appropriate
palliative care services (pain relief, access to opioids, palliative
radiation therapy, spiritual and psychosocial support to patients
and families) to improve the quality of life of patients and their
families [7,28]. However, this area also requires improvement,
since resources are used mainly for curative treatments rather than
palliative care. Moreover, these services, when available in the
private sector, are often under-utilized since insurance reimburse-
ment mechanisms are unclear [7]. Opioid medications such as oral
morphine for pain management are generally available in only 50%
of the countries and are generally covered by health insurance orpublicly funded, and are included in the national list of essential
medicines in 64% of the countries [28].
A range of other problems are associated with delivery of
effective cancer care within the Central and South American
region, including the concentration of diagnostic and treatment
services in large urban centers, the limited human resources with
expertise in cancer, and the existence of other health problems
such as infectious diseases and external causes that require a
greater effort of the health systems in this region compared to that
in more developed countries [31].
4. Cancer registration
Only a few population-based cancer registries in the region
have high-quality data published in the Cancer Incidence in Five
Continents (CI5) series. Although the number of registries in the
region has increased from one in CI5 Volume I (published in 1966)
to 22 in Volume X (published in 2014), there is still a lack of
coverage for most countries. In the latest volume of CI5, only 36% of
countries located in Central and South American region were
included (Argentina, Brazil, Chile, Colombia, Costa Rica, Cuba,
Ecuador, Peru and Uruguay), covering approximately 8% of the
population as compared to 96% coverage in the United States [32].
All the population-based registries are regional registries, except
for those in Costa Rica and Uruguay which have national coverage.
Cancer mortality data are derived from vital registration systems
where the underlying causes of death are certiﬁed. Mortality data
quality in some countries of the Central and South American region
may be considered to be medium or low quality (<80% coverage)
[22]. Nevertheless these data provide valuable information to
describe the cancer burden since they may be the only source of
information available on cancer. Information concerning trends in
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scarce due to the low number of population-based cancer registries
continuously collecting cancer incidence data. Similarly, compara-
ble data and statistics on cancer mortality are sparse in spite of the
efforts made in the last decade. Therefore, knowledge of
geographic patterns of cancer incidence and mortality in the
Central and South American region as a whole usually come from
data estimations from GLOBOCAN [23], which are the most current
and comprehensive global statistics on cancer. However, complex
methods may be required to estimate them given that most
countries in the region lack or do not have high-quality incidence
data; mortality data are of medium- to high-quality in most Central
American countries, whereas data are of low quality in Argentina,
Paraguay and Suriname, and are lacking altogether in Bolivia and
Nicaragua [33].
5. Objective
The aim of this project was to describe the current patterns of
cancer incidence and mortality in the Central and South American
region (together with Cuba1) in the 21st century by obtaining the
best available cancer data from each country located in the region.
The secondary objective was to evaluate the burden of several
speciﬁc sites of cancer and to review their epidemiology and
prospects for prevention within the region. These sites were
selected based on (1) burden, (2) research projects by IARC in the
region, and (3) importance to the region or speciﬁc countries
within the region (e.g. gallbladder cancer).
Unlike GLOBOCAN [23], which makes use of available data to
provide national estimates, this project aimed to make available
observed incidence data collected by cancer registries and present
these data in a consistent and comparable format. Alongside
incidence data, mortality data collected by national vital statistics
ofﬁces and reported to WHO are also reported. Unlike CI5 [32],
datasets provided by cancer registries were not subject to any
quality evaluation process, and all those received from population-
based registries were included in the tabulations and analyses. In
one or two instances, where a country had no population-based
registries able to report data, information from hospital-based
registries were requested and are presented. While this means that
the quality of data provided is inevitably variable, largely a function
of the age and development in maturity of the registries, the
process provides some incidence information on many more
regions and countries than in CI5, thus enabling a different
perspective on the regional pattern.
Thus incidence data have been made available here from
48 cancer registries in 13 countries, compared with 22 registries in
eight countries in CI5 Volume X. Additionally, hospital-based
registry data were available for ﬁve countries.
This compilation of “all available” cancer data will be, we hope,
of value to national agencies in governmental and NGO sectors
involved in cancer control activities, and will also provide insights
into the burden and pattern of cancer in countries and regions of
countries which have hitherto been unreported. Quality indicators
for the data provided are also presented and are important
parameters to consider when making use of the data in this
supplement issue. Also, even though there has been no selection
based on quality, all datasets received were passed through the
same standard data quality control and checking procedures as1 Cuba was included with other countries from Central and South America in this
study because of the shared Latin-American heritage and culture. Cuba also has
cancer registries that are member organizations of the International Association of
Cancer Registries (IACR) and the country is the only Caribbean member of the Red
de Institutos e Instituciones Nacionales de Cancer (RINC) organization.used in CI5 [32], and registries were then contacted to correct
identiﬁed errors and inconsistencies.
6. Outline
This supplement issue of Cancer Epidemiology on “Cancer in
Central and South America” comprises, following this introduction, a
paper describing the methods employed in the collection, quality
control and analysis of the datasets received for the project. This is
then followed by a general paper looking at the totality of the data
and providing a broad overview of cancer incidence and mortality
patterns within the entire region, considering the geographical
variation between countries for each site and type of cancer and, to
the extentpossible, trends overtime.Subsequently there isa series of
14 cancer site-speciﬁc papers looking in detail at the geographic and
temporal patterns for major cancers and accompanying these
descriptive analyses with a review of identiﬁed risk factors for the
cancer concerned and how these may lead to policies for prevention
within the region. Where cancers may be diagnosed early, or in a
precancerous phase, through screening or surveillance, this is also
considered from the perspective of Central and South America.
Additional material to the supplement issue is available online
through the “Cancer in Central and South America” website (http://
www-dep.iarc.fr/CSU_resources.htm). This material comprises a
set of cancer proﬁles for each of the 22 countries within the region
(standard tables andgraphics for each country and each contribut-
ing registry), and complementary etiologic information related to
the 14 speciﬁc sites of cancer evaluated in detail.
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Appendix.
Cancer in Central and South America (CSA) Working Group
Argentina: Eduardo A. Laura [Registry of Tumors of the South of
Buenos Aires Province], Guillermo Martín Roa [Cancer Registry of
D. Forman, M.S. Sierra / Cancer Epidemiology (2016) S3–S10 S9Chaco Province], Martin Alonso [Córdoba Cancer Registry], María
Cristina Diumenjo [Provincial Registry of Tumors of Mendoza],
Adriana Feltri [Neuquén Cancer Registry], Maria Abigail Green
[Cancer Registry Santa Fe], Susana Graciela Ibañez [Population-
based Cancer Registry of the Province of Tierra del Fuego]; Bolivia
(Plurinational State of): Sdenka Maury [Cancer Registry of La
Paz]; Brazil: Carlos Anselmo Lima [Cancer Registry of Aracaju],
Lucrecia Aline Cabral Formigosa [Population-based Cancer Registry
of Belem], Berenice Navarro Antoniazzi [Population-based Cancer
Registry of Belo Horizonte/MG/Brazil], Nazira Mahayri [Popula-
tion-based Cancer Registry of Campinas], Glaucia da Silva Nunes de
Freitas [Population-based Cancer Registry of Campo Grande de
Mato Grosso do Sul], Maria Jose Lemes De Oliveira Sales
[Population-based Cancer Registry of Cuiabá], Cyntia Asturian
Laporte [Population-based Cancer Registry of Curitiba], Miren
Maite Uribe Arregi [Fortaleza City Cancer Registry], Jose Carlos de
Oliveira [Cancer Registry of Goiânia], Jose Getulio Martins Segalla
[Population-based Cancer Registry of Jaú], Josefa Angela Pontes de
Aquino [Cancer Registry of João Pessoa], Nayara Cabral Machado
[Population-based Cancer Registry of Manaus], Severina Pereira de
Oliveira [Population-based Cancer Registry of Natal-RN], Angela
Maria Schmidt [Population-based Cancer Registry of Porto Alegre],
Claudia Cristina Lima de Castro [Population-based Cancer Registry
of Recife], Elmando Sampaio Silva [Population-based Cancer
Registry of Salvador], Fernanda Alessandra Silva Michels [Popula-
tion-based Cancer Registry of São Paulo City], Maria Amelia de
Oliveira [Population-based Cancer Registry of Piauí (Teresina)],
Yula de Lima Merola [Population-based Cancer Registry of Poços de
Caldas]; Chile: Juan Carlos Galaz Alamos [Cancer Registry, Region
of Antofagasta], Ana María Jofré Salazar [Valdivia Cancer Registry];
Colombia: Claudia Janeth Uribe [Cancer Registry of the Metropol-
itan Area of Bucaramanga], Luis Eduardo Bravo [Cali Cancer
Registry], Guillermo Antonio Lopez Guarnizo [Population-based
Cancer Registry of Manizales], Maria Clara Yepez Chamorro
[Cancer Registry of Pasto]; Costa Rica: Marìa Ethel Trejos [Costa
Rica National Tumour Registry]; Cuba: Yaima Galán Alvarez [Villa
Clara Cancer Registry]; Ecuador: Nicolas Campoverde [Cuenca
Tumor Registry], Patricia Cueva [National Cancer Registry]; El
Salvador: Gonzalo Beltran Castro, Salvador Diaz Bazan [El Salvador
Tumor Registry]; French Guyana: Juliette Plenet [French Guiana
Cancer Registry]; Guatemala: Mynor R. Villeda, Carlos Waldheim
[National Cancer Registry of Guatemala]; Honduras: Flora Duarte
[National Cancer Registry of Honduras]; Mexico: María de las
Mercedes Basulto Monroy [Jalisco State Cancer Registry];
Nicaragua: Ofelia G. Rojas Berrios [Nicaragua Cancer Registry of
Léon]; Panama: Nedelka Pinzon [Panama National Cancer Regis-
try]; Paraguay: José Estanislao Barreto Portillo [Paraguay National
Cancer Registry]; Peru: Luis E. Medina Fernández [Population-
based Cancer Registry of Arequipa], Pedro F. Albujar [Trujillo
Cancer Registry], Eduardo Payet [Metropolitan Lima Cancer
Registry]; Uruguay: Enrique Barrios [National Cancer Registry of
Uruguay].
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